How Aging Fat Around Blood Vessels Drives Oxidative Damage and Vascular Decline

Cardiovascular disease risk rises sharply with age, and researchers are increasingly looking beyond the vessel wall itself to understand why. Perivascular adipose tissue (PVAT), the fat depot directly surrounding arteries and veins, has emerged as a critical but underappreciated regulator of vascular health — and a key site of age-related deterioration.

In healthy physiology, PVAT acts as a redox buffer: it limits oxidative stress, maintains nitric oxide bioavailability, and releases vasoprotective signals. This review by Liu et al. synthesizes current evidence showing how aging systematically dismantles these functions. Mitochondrial dysfunction drives excess reactive oxygen species (ROS) generation, while antioxidant enzyme systems — including superoxide dismutase and catalase pathways — become progressively impaired.

A particularly novel contribution of this review is its focus on ferroptosis within PVAT. Ferroptosis is a regulated form of cell death driven by iron dysregulation and uncontrolled lipid peroxidation. The authors argue that aging-associated iron dyshomeostasis in PVAT, combined with disruption of the GPX4-glutathione antioxidant axis, creates conditions highly permissive for ferroptotic cell death. This not only destroys PVAT cells but amplifies inflammatory and oxidative signaling into the adjacent vessel wall.

The downstream consequences are substantial: endothelial dysfunction, impaired vasodilation, and structural vascular remodeling — all hallmarks of age-related cardiovascular disease. PVAT transitions from a protective neighbor to an active driver of vascular pathology.

Because this is a review article based solely on the abstract, the precise scope of studies analyzed, inclusion criteria, and specific mechanistic models are not fully characterizable. Nevertheless, the conceptual framework linking PVAT redox remodeling, ferroptosis, and vascular aging is timely and could guide future therapeutic targeting of GPX4 or iron metabolism in cardiovascular aging.